Report: "High prices, poor access: the EU medicines market and Big Pharma" | What is Big Pharma fighting for in Brussels?



The pharmaceutical industry is one of the world’s most profitable, benefiting from a highly problematic model, which helps ensure many people still lack access to essential, life-saving medicines. While this has been a major issue in the global South for decades, the crisis engulfing affordable medicines is now also spreading in Europe.

CONTINUE READING ON corporateeurope.org

                   

Related News

Loading...